Screening High-Risk Groups and the General Population for SARS-CoV-2 Nucleic Acids in a Mobile Biosafety Laboratory

The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) pandemic has challenged public health systems worldwide. Therefore, large-scale testing capacity is extremely important diagnosis and exclusion diagnosis. However, fixed laboratories are limited or far away from remote areas. Fortunate...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Zhimin, Li, Lin, Song, Yuanyuan, Xu, Jiancheng, Huang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414879/
https://www.ncbi.nlm.nih.gov/pubmed/34485233
http://dx.doi.org/10.3389/fpubh.2021.708476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414879/
https://www.ncbi.nlm.nih.gov/pubmed/34485233
http://dx.doi.org/10.3389/fpubh.2021.708476

Ejemplares similares